title: Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).
authors.affiliation: Department of Dermatology and INSERM U1058, Hôpital Saint-Eloi, 80 avenue Augustin Fliche, 34295 Montpellier cedex 5, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Du-Thanh
authors.affiliation: Department of Dermatology and INSERM U1058, Hôpital Saint-Eloi, 80 avenue Augustin Fliche, 34295 Montpellier cedex 5, France.
authors.forename: Céline
authors.initials: C
authors.lastname: Girard
authors.affiliation: Department of Hepato-gastro-enterology University Montpellier 1, Montpellier, France.
authors.forename: Georges-Philippe
authors.initials: GP
authors.lastname: Pageaux
authors.affiliation: Department of Dermatology and INSERM U1058, Hôpital Saint-Eloi, 80 avenue Augustin Fliche, 34295 Montpellier cedex 5, France.
authors.forename: Bernard
authors.initials: B
authors.lastname: Guillot
authors.affiliation: Department of Dermatology and INSERM U1058, Hôpital Saint-Eloi, 80 avenue Augustin Fliche, 34295 Montpellier cedex 5, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Dereure
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000009:adverse effects*; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib